NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Global Vascular Co., Ltd.

Global Vascular Co., Ltd.

Private
TokyoHealthcare & Life Scienceshttps://www.g-vasc.com/

Last Round

Series B

Jun 30, 2025

Est. Valuation

$31.84M

Total Funding Raised

$16.72M

Company Overview

Global Vascular Co., Ltd. is a medical device company that develops a drug-eluting stent delivery system for the treatment of lower limb artery disease.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotechnology, Clinical Trials

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

drug-eluting stentperipheral arterial diseasePADendovascular treatmentbelow-the-kneeBTKmedical devicenanotechnologybiocompatibilityvascular surgeryinterventional cardiologystent delivery systemthrombus suppressionmedtechvascular intervention

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Global Vascular Co., Ltd. Comps

Public and private peers based on sector, stage, and business model.

Global Vascular Co., Ltd. comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Global Vascular Co., Ltd. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BJun 30, 2025
Series ADec 5, 2023
SeedMay 9, 2023

Key People

Founding team and executive leadership

Kenta Bito

代表取締役CEO

Executive Team

Shunto Maegawa

Chief Technology Officer

Executive Team

Emi Matsuoka

Chief Operating Officer

Executive Team

Global Vascular Co., Ltd. Investors

Notable investors and investment history

Global Vascular Co., Ltd. investors
InvestorRounds
Sumitomo Mitsui Trust BankSeries B
Diamond Medino CapitalSeries B, Series A, Seed
Tokyo University of Science Investment ManagementSeries A
Tokyo University of Science Innovation CapitalSeries B, Series A
Mitsui Sumitomo InsuranceSeries B
Mitsubishi UFJ CapitalSeries B, Series A
Fast Track InitiativeSeries B, Series A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 30, 2025

    $7M round with Sumitomo Mitsui Trust Bank and Diamond Medino Capital.

  • Dec 5, 2023

    $8M round led by Diamond Medino Capital.

Global Vascular Co., Ltd. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Global Vascular Co., Ltd. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Global Vascular Co., Ltd.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersTokyo
Employee Range8
Year Founded2022
Last FundingJun 30, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.